Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernd Meibohm

Showing results (1-10 of 171) with videos related to

Pageof 18
Sort By:
Clinical Pharmacokinetics|November 18, 2011
Population pharmacokinetic/pharmacodynamic analyses as the basis for dosing of therapeutic monoclonal antibodiesBernd Meibohm
Clinical Pharmacokinetics|September 13, 2014
Protein engineering for improved pharmacologic characteristics of established monoclonal antibody-based therapeuticsBernd Meibohm
Frontiers in Pharmacology|February 28, 2022
Knowledge Gaps in the Pharmacokinetics of Therapeutic Proteins in Pediatric PatientsBernd Meibohm
Journal of Pharmaceutical Sciences|January 10, 2002
Pharmacokinetic/pharmacodynamic studies in drug product developmentBernd Meibohm, Hartmut Derendorf
Handbook of Experimental Pharmacology|September 2, 2011
Study design and simulation approachStephanie Läer, Bernd Meibohm
Expert Opinion on Drug Metabolism & Toxicology|May 5, 2015
Tools for predicting the PK/PD of therapeutic proteinsLei Diao, Bernd Meibohm
European Journal of Drug Metabolism and Pharmacokinetics|July 28, 2025
Revisiting the Role of Plasma-to-Blood Partitioning in PharmacokineticsAmarinder Singh, Bernd Meibohm
Journal of Clinical Pharmacology|February 25, 2015
Clinical pharmacology of bispecific antibody constructsChetan Rathi, Bernd Meibohm
Journal of Clinical Pharmacology|January 11, 2012
Characterizing the impact of renal impairment on the clinical pharmacology of biologicsBernd Meibohm, Honghui Zhou
Clinical Pharmacokinetics|May 31, 2013
Pharmacokinetics and pharmacokinetic-pharmacodynamic correlations of therapeutic peptidesLei Diao, Bernd Meibohm
Pageof 18

Showing results (1-10 of 171) with videos related to

Sort By:
Pageof 18
Clinical Pharmacokinetics|November 18, 2011
Population pharmacokinetic/pharmacodynamic analyses as the basis for dosing of therapeutic monoclonal antibodiesBernd Meibohm
Clinical Pharmacokinetics|September 13, 2014
Protein engineering for improved pharmacologic characteristics of established monoclonal antibody-based therapeuticsBernd Meibohm
Frontiers in Pharmacology|February 28, 2022
Knowledge Gaps in the Pharmacokinetics of Therapeutic Proteins in Pediatric PatientsBernd Meibohm
Journal of Pharmaceutical Sciences|January 10, 2002
Pharmacokinetic/pharmacodynamic studies in drug product developmentBernd Meibohm, Hartmut Derendorf
Handbook of Experimental Pharmacology|September 2, 2011
Study design and simulation approachStephanie Läer, Bernd Meibohm
Expert Opinion on Drug Metabolism & Toxicology|May 5, 2015
Tools for predicting the PK/PD of therapeutic proteinsLei Diao, Bernd Meibohm
European Journal of Drug Metabolism and Pharmacokinetics|July 28, 2025
Revisiting the Role of Plasma-to-Blood Partitioning in PharmacokineticsAmarinder Singh, Bernd Meibohm
Journal of Clinical Pharmacology|February 25, 2015
Clinical pharmacology of bispecific antibody constructsChetan Rathi, Bernd Meibohm
Journal of Clinical Pharmacology|January 11, 2012
Characterizing the impact of renal impairment on the clinical pharmacology of biologicsBernd Meibohm, Honghui Zhou
Clinical Pharmacokinetics|May 31, 2013
Pharmacokinetics and pharmacokinetic-pharmacodynamic correlations of therapeutic peptidesLei Diao, Bernd Meibohm
Pageof 18